Cinclus Pharma Holding AB (publ) (STO:CINPHA)
Sweden · Delayed Price · Currency is SEK 12.22
+0.06 (0.49%)
At close: Jun 15, 2026
Cinclus Pharma Holding AB Market Cap
Cinclus Pharma Holding AB has a market cap or net worth of 568.69 million as of June 15, 2026. Its market cap has decreased by -14.78% in one year.
Market Cap
568.69M
Enterprise Value
145.77M
Revenue
67.51M
Ranking
n/a
PE Ratio
n/a
Stock Price
12.22
Market Cap Chart
Since June 20, 2024, Cinclus Pharma Holding AB's market cap has decreased from 1.52B to 568.69M, a decrease of -62.52%. That is a compound annual growth rate of -38.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 15, 2026 | 568.69M | -36.55% |
| Dec 30, 2025 | 896.32M | -9.92% |
| Dec 30, 2024 | 994.98M | -34.43% |
| Jun 20, 2024 | 1.52B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioGaia AB | 12.59B |
| Cereno Scientific AB | 1.69B |
| Nanexa AB | 814.91M |
| Orexo AB | 745.58M |
| EQL Pharma AB | 724.95M |
| Enzymatica AB | 631.11M |
| Dicot Pharma AB | 481.84M |
| Moberg Pharma AB | 467.66M |